Pubblicazioni

Survival outcomes in patients with previously untreated BRAF wild-type advanced melanoma treated with nivolumab therapy. three-year follow-up of a randomized phase 3 trial

2019 - JAMA ONCOLOGY

Ascierto, P. A.; Long, G. V.; Robert, C.; Brady, B.; Dutriaux, C.; Di Giacomo, A. M.; Mortier, L.; Hassel, J. C.; Rutkowski, P.; Mcneil, C.; Kalinka-Warzocha, E.; Savage, K. J.; Hernberg, M. M.; Lebbe, C.; Charles, J.; Mihalcioiu, C.; Chiarion-Sileni, V.; Mauch, C.; Cognetti, F.; Ny, L.; Arance, A.; Svane, I. M.; Schadendorf, D.; Gogas, H.; Saci, A.; Jiang, J.; Rizzo, J.; Atkinson, V.